NASDAQ
Edwards Lifesciences Corporation (EW) has a free cash flow growth of -105.97% as of Friday, May 29, 2026. This represents a 233.85% decrease compared to its 12-month average of 79.17%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.